These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1290289)

  • 21. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S; Duker G; Carlsson L
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the antiarrhythmic profile of the new class I agent diprafenone.
    Gülker H; Thale J; Olbing B; Heuer H; Frenking B; Bender F
    Arzneimittelforschung; 1985; 35(9):1387-93. PubMed ID: 4084340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
    Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS
    Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Arrhythmias and heart failure].
    Amann FW; Candinas R
    Ther Umsch; 1993 Jun; 50(6):419-24. PubMed ID: 8351673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Magnesium as an anti-arrhythmic therapy principle in supraventricular and ventricular cardiac arrhythmias].
    Zehender M
    Z Kardiol; 1996; 85 Suppl 6():135-45. PubMed ID: 9064958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-arrhythmic and cardiodepressive effects of anti-arrhythmia agents].
    Scholz H
    Z Kardiol; 1988; 77 Suppl 5():113-9. PubMed ID: 2464875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of naloxone on rhythm disorders and on the conduction system of the heart].
    Shliakhto EV; Zaĭtsev AA; Panov AV; Ardashev AV; Nifontov EM; Kashina EA; Kazarin VV; Ivanov VV
    Eksp Klin Farmakol; 1996; 59(3):34-6. PubMed ID: 8974581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-arrhythmia drugs in geriatric patients].
    Hohnloser SH; Zabel M
    Fortschr Med; 1991 Aug; 109(25):492-5. PubMed ID: 1937335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Electric stability of the heart after myocardial infarction: role of anti-arrhythmia agents during postinfarction].
    Sadoul N; Aliot E
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):773-80. PubMed ID: 1356328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The influence of antiarrhythmic drugs on parameters of signal-averaged electrocardiography].
    Banasiak W; Bobak J; Telichowski A
    Przegl Lek; 1997; 54(7-8):510-4. PubMed ID: 9480459
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental and initial clinical experiences with the new class Ib anti-arrhythmia agent barucainide].
    Gülker H; Heuer H; Frenking B; Haverkamp W; Hindricks G; Bozek B; Bremkes C; Asche KD; Witthöft D
    Z Kardiol; 1988 Sep; 77(9):587-94. PubMed ID: 2461620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of anti-arrhythmia drugs on the heart conduction system].
    Walczak F
    Kardiol Pol; 1992; 36(2):92-6. PubMed ID: 1583832
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cardiac side effects of anti-arrhythmia agents].
    Seipel L
    Z Kardiol; 1988 Feb; 77(2):77-88. PubMed ID: 3284219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A method for experimental study of arrhythmias following myocardial infarction in closed-chest dog. Its use as a test for antiarrhythmic drugs [proceedings].
    Dupuis B; Gautier P; Richer G; Serre M
    Br J Pharmacol; 1976 Nov; 58(3):409P. PubMed ID: 990597
    [No Abstract]   [Full Text] [Related]  

  • 35. Experimental models of reentry, antiarrhythmic, and proarrhythmic actions of drugs. Complexities galore!
    el-Sherif N
    Circulation; 1991 Oct; 84(4):1871-5. PubMed ID: 1914122
    [No Abstract]   [Full Text] [Related]  

  • 36. Basic Cardiac Electrophysiology and Common Drug-induced Arrhythmias.
    Lee A; Pickham D
    Crit Care Nurs Clin North Am; 2016 Sep; 28(3):357-71. PubMed ID: 27484663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Myocardial model arrhythmias and anti-arrhythmic principles].
    Buntenkötter S
    Dtsch Tierarztl Wochenschr; 1978 Jun; 85(6):260-5. PubMed ID: 350552
    [No Abstract]   [Full Text] [Related]  

  • 38. Botulinum Toxin-Chitosan Nanoparticles Prevent Arrhythmia in Experimental Rat Models.
    Sergeevichev D; Fomenko V; Strelnikov A; Dokuchaeva A; Vasilieva M; Chepeleva E; Rusakova Y; Artemenko S; Romanov A; Salakhutdinov N; Chernyavskiy A
    Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32748868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic drug treatment: need for continuous vigilance.
    Wellens HJ; Smeets JL; Vos M; Gorgels AP
    Br Heart J; 1992 Jan; 67(1):25-33. PubMed ID: 1739521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Water-Soluble Echinochrome Analog on Arrhythmia Severity in Experimental Model of Acute Myocardial Ischemia.
    Bernikova OG; Sedova KA; Kharin SN; Azarov YE
    Bull Exp Biol Med; 2018 Jul; 165(3):340-343. PubMed ID: 30006880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.